Search Ontology:
ChEBI
(1R)-1,5-anhydro-1-[(3S,4S,5R)-3-(hexacosanoylamino)-4,5-dihydroxynonadecyl]-D-galactitol
- Term ID
- CHEBI:552760
- Synonyms
-
- (1R)-1,5-anhydro-1-[(3S,4S,5R)-3-(hexacosanoylamino)-4,5-dihydroxynonadecyl]-D-galactitol
- (2S,3S,4R)-1-CH2-(alpha-D-galactopyranosyl)-2-(N-hexacosanoylamino)-1,3,4-octadecanetriol
- (2S,3S,4R)-1-CH2-(alpha-D-galactopyranosyl)-2-hexacosanamido-1,3,4-octadecanetriol
- (3'S,4'S,5'R)-1-C-(3'-hexacosanoylamino-4',5'-dihydroxynonadecyl)-alpha-D-galactopyranoside
- Definition
- A C-glycosylphytoceramide consisting of 1-O-(alpha-D-galactopyranosyl)-N-hexacosanylphytosphingosine with the anomeric oxygen replaced by a methylene group.
- References
-
- PMID:14657217
- PMID:15258945
- PMID:15496103
- PMID:18993065
- PMID:19949076
- PMID:22195564
- Reaxys:9984901
- Ontology
- ChEBI ( EBI )
- is a type of
-
Phenotype
Phenotype resulting from (1R)-1,5-anhydro-1-[(3S,4S,5R)-3-(hexacosanoylamino)-4,5-dihydroxynonadecyl]-D-galactitol
Phenotype where environments contain (1R)-1,5-anhydro-1-[(3S,4S,5R)-3-(hexacosanoylamino)-4,5-dihydroxynonadecyl]-D-galactitol
Phenotype modified by environments containing (1R)-1,5-anhydro-1-[(3S,4S,5R)-3-(hexacosanoylamino)-4,5-dihydroxynonadecyl]-D-galactitol
Human Disease Model